Hypocalcemia with Immune Checkpoint Inhibitors: The Disparity among Various Reports

Immune-related adverse events affecting parathyroid function are rarely reported with immune checkpoint inhibitors (ICPIs). Activating calcium-sensing receptor antibodies causing autoimmune hypoparathyroidism with nivolumab was recently reported. KEYNOTE-189 and CHECKMATE-067 trials reported a 21–29...

Descripción completa

Detalles Bibliográficos
Autores principales: Nalluru, Swarna Sri, Piranavan, Paramarajan, Ning, Ying, Ackula, Haritha, Siddiqui, Ahmad D., Trivedi, Nitin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294349/
https://www.ncbi.nlm.nih.gov/pubmed/32587615
http://dx.doi.org/10.1155/2020/7459268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294349/
https://www.ncbi.nlm.nih.gov/pubmed/32587615
http://dx.doi.org/10.1155/2020/7459268

Ejemplares similares